Icon

VEPESID (nda018768)- (20MG/ML)

ETOPOSIDE CORDEN PHARMA
20MG/ML
No No
Expired Expired
None None
None No
VePesid (etoposide) is indicated in the management of the following neoplasms: *Refractory Testicular Tumors—VePesid For Injection in combination therapy with other approved chemotherapeutic agents in patients with refractory testicular tumors who have already received appropriate surgical, chemotherapeutic, and radiotherapeutic therapy. *Small Cell Lung Cancer—VePesid For Injection and/or Capsules in combination with other approved chemotherapeutic agents as first line treatment in patients with small cell lung cancer.
4 0 4
Total Other Developers None
Drugs with Suitability No
20MG/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
No 4
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ********** **** ********* *********** ************ **, **********, ***** ****** *****, ******* (***) ***
****** ****** ******** ***** *************** ******* *********** **** **. ***/***-****** / **** **.***/****-*********** , *******-***** ******* , ****** -******, ******, *********, ******* ******, ***** (***) ***
****** ********* **** *** ********* **** ***, *** *********** **** *. **** ****** **** ***** ********* ******, ******* ****, ******** (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.